Cooked navy and black bean diets improve biomarkers of colon health and reduce inflammation during colitis

British Journal of Nutrition

Volumn 111, Issue 9, 2014, Pages 1549-1563

  Zhang, Claire ^a,b   Monk, Jennifer M ^a,b   Lu, Jenifer T ^a,b   Zarepoor, Leila ^a,b   Wu, Wendy ^a   Liu, Ronghua ^a   Pauls, K Peter ^b   Wood, Geoffrey A ^b   Robinson, Lindsay ^b   Tsao, Rong ^a   Power, Krista A ^a,b  

^a GUELPH RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Black beans; Colitis; Colon health; Dextran sodium sulphate; Inflammation; Navy beans; SCFA

Indexed keywords

ANTHOCYANIN; CASPASE 3; FAS LIGAND; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 9; MESSENGER RNA; MYELOPEROXIDASE; PHENOL DERIVATIVE; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BEAN; COLON MUCOSA; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY; FLOUR; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS;

MUS;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASPASE 3; CECUM; COLITIS; COLON; COOKING; CYTOKINES; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; FATTY ACIDS, VOLATILE; FECES; FUNCTIONAL FOOD; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PHASEOLUS; SEEDS;

EID: 84898011919     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513004352     Document Type: Article

References (135)

1. Bischoff SC (2011) 'Gut health': A new objective in medicine?. BMC Med 9, 24
2. Cerf-Bensussan N & Gaboriau-Routhiau V (2010) The immune system and the gut microbiota: Friends or foes?. Nat Rev Immunol 10, 735-744
3. Zhu Y, Michelle Luo T, Jobin C, et al. (2011) Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett 309, 119-127
4. Sanz Y, Santacruz A & Gauffin P (2010) Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 69, 434-441
5. Harris K, Kassis A, Major G, et al. (2012) Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?. J Obes 2012, 879151
6. Kelly D & Mulder IE (2012) Microbiome and immunological interactions. Nutr Rev 70, Suppl. 1, S18-S30
7. Dilis V & Trichopoulou A (2009) Nutritional and health properties of pulses. Mediterr J Nutr Metab 1, 149-157
8. Gebrelibanos M, Tesfaye D, Raghavendra Y, et al. (2013) Nutritional and health implications of legumes. Int J Pharm Sci Res 4, 1269-1279
9. Mathers JC (2002) Pulses and carcinogenesis: Potential for the prevention of colon, breast and other cancers. Br J Nutr 88, Suppl. 3, S273-S279
10. Finley JW, Burrell JB & Reeves PG (2007) Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. J Nutr 137, 2391-2398
11. Henningsson AM, Nyman EM & Bjorck IM (2001) Content of short-chain fatty acids in the hindgut of rats fed processed bean (Phaseolus vulgaris) flours varying in Distribution and content of indigestible carbohydrates. Br J Nutr 86, 379-389
12. Hernandez-Salazar M, Osorio-Diaz P, Loarca-Pina G, et al. (2010) In vitro fermentability and antioxidant capacity of the indigestible fraction of cooked black beans (Phaseolus vulgaris L.), lentils (Lens culinaris L.) and chickpeas (Cicer arietinum L.). J Sci Food Agric 90, 1417-1422
13. Vergara-Castaneda HA, Guevara-Gonzalez RG, Ramos-Gomez M, et al. (2010) Non-digestible fraction of cooked bean (Phaseolus vulgaris L.) cultivar Bayo Madero suppresses colonic aberrant crypt foci in azoxymethaneinduced rats. Food Funct 1, 294-300
14. Hayde VC, Ramon GG, Lorenzo GO, et al. (2012) Non-digestible fraction of beans (Phaseolus vulgaris L.) modulates signalling pathway genes at an early stage of colon cancer in Sprague-Dawley rats. Br J Nutr 108, Suppl. 1, S145-S154
15. Correa P (1981) Epidemiological correlations between Diet and cancer frequency. Cancer Res 41, 3685-3690
16. Lanza E, Hartman TJ, Albert PS, et al. (2006) High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J Nutr 136, 1896-1903
17. Bobe G, Barrett KG, Mentor-Marcel RA, et al. (2008) Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr Cancer 60, 373-381
18. Bobe G, Sansbury LB, Albert PS, et al. (2008) Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 17, 1344-1353
19. Campos-Vega R, Reynoso-Camacho R, Pedraza-Aboytes G, et al. (2009) Chemical composition and in vitro polysaccharide fermentation of different beans (Phaseolus vulgaris L.). J Food Sci 74, T59-T65
20. Cruz-Bravo RK, Guevara-Gonzalez R, Ramos-Gomez M, et al. (2011) Fermented nondigestible fraction from common bean (Phaseolus vulgaris L.) cultivar Negro 8025 modulates HT-29 cell behavior. J Food Sci 76, T41-T47
21. Lin L-Z, Harnly JM, Pastor-Corrales MS, et al. (2008) The polyphenolic profiles of common bean (Phaseolus vulgaris L.). Food Chem 107, 399-410
22. Leonel AJ & Alvarez-Leite JI (2012) Butyrate: Implications for intestinal function. Curr Opin Clin Nutr Metab Care 15, 474-479
23. Hamer HM, Jonkers D, Venema K, et al. (2008) Review article: The role of butyrate on colonic function. Aliment Pharmacol Ther 27, 104-119
24. Roediger WE (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793-798
25. Langlands SJ, Hopkins MJ, Coleman N, et al. (2004) Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53, 1610-1616
26. Kim YS & Milner JA (2007) Dietary modulation of colon cancer risk. J Nutr 137, 2576S-2579S.
27. Butzner JD, Parmar R, Bell CJ, et al. (1996) Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38, 568-573
28. Di Sabatino A, Morera R, Ciccocioppo R, et al. (2005) Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther 22, 789-794
29. Scheppach W, Sommer H, Kirchner T, et al. (1992) Effect of butyrate enemas on the colonic mucosa in Distal ulcerative colitis. Gastroenterology 103, 51-56
30. Segain JP, Raingeard de la Bletiere D, Bourreille A, et al. (2000) Butyrate inhibits inflammatory responses through NF-kappaB inhibition: Implications for Crohn's disease. Gut 47, 397-403
31. Steinhart AH, Hiruki T, Brzezinski A, et al. (1996) Treatment of left-sided ulcerative colitis with butyrate enemas: A controlled trial. Aliment Pharmacol Ther 10, 729-736
32. Tedelind S, Westberg F, Kjerrulf M, et al. (2007) Antiinflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World J Gastroenterol 13, 2826-2832
33. Cardona F, Andres-Lacueva C, Tulipani S, et al. (2013) Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 24, 1415-1422
34. Guajardo-Flores D, Serna-Saldivar SO & Gutierrez-Uribe JA (2013) Evaluation of the antioxidant and antiproliferative activities of extracted saponins and flavonols from germinated black beans (Phaseolus vulgaris L.). Food Chem 141, 1497-1503
35. Kumazaki M, Noguchi S, Yasui Y, et al. (2013) Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. J Nutr Biochem 24, 1849-1858
36. Banerjee N, Kim H, Talcott S, et al. (2013) Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: Possible role of miR-126/VCAM-1 and miR-126/PI3K/AKT/mTOR. Carcinogenesis 34, 2814-2822
37. Sung MK & Park MY (2013) Nutritional modulators of ulcerative colitis: Clinical efficacies and mechanistic view. World J Gastroenterol 19, 994-1004
38. Yao J, Wang JY, Liu L, et al. (2010) Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis. Arch Med Res 41, 288-294
39. Romier B, Schneider YJ, Larondelle Y, et al. (2009) Dietary polyphenols can modulate the intestinal inflammatory response. Nutr Rev 67, 363-378
40. Kim SJ, Kim MC, Um JY, et al. (2010) The beneficial effect of vanillic acid on ulcerative colitis. Molecules 15, 7208-7217
41. Park MY, Ji GE & Sung MK (2012) Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice. Dig Dis Sci 57, 355-363
42. Dong WG, Liu SP, Yu BP, et al. (2003) Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J Gastroenterol 9, 2533-2538
43. Ulluwishewa D, Anderson RC, McNabb WC, et al. (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141, 769-776
44. Suzuki T & Hara H (2011) Role of flavonoids in intestinal tight junction regulation. J Nutr Biochem 22, 401-408
45. Tuohy KM, Conterno L, Gasperotti M, et al. (2012) Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber. J Agric Food Chem 60, 8776-8782
46. Hervert-Hernández D & Goñi I (2011) Dietary polyphenols and human gut microbiota: A review. Food Rev Int 27, 154-169
47. Etxeberria U, Fernandez-Quintela A, Milagro FI, et al. (2013) Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem 61, 9517-9533
48. Rubin DC, Shaker A & Levin MS (2012) Chronic intestinal inflammation: Inflammatory bowel disease and colitisassociated colon cancer. Front Immunol 3, 107
49. Lakatos PL & Lakatos L (2008) Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J Gastroenterol 14, 3937-3947
50. Sha S, Xu B, Wang X, et al. (2013) The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagn Microbiol Infect Dis 75, 245-251
51. Fabia R, Ar'Rajab A, Johansson ML, et al. (1993) Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 54, 248-255
52. Takaishi H, Matsuki T, Nakazawa A, et al. (2008) Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 298, 463-472
53. Sasaki M & Klapproth JM (2012) The role of bacteria in the pathogenesis of ulcerative colitis. J Signal Transduct 2012, 704953
54. de Wouters T, Dore J & Lepage P (2012) Does our food (environment) change our gut microbiome ('in-vironment'): A potential role for inflammatory bowel disease?. Dig Dis 30, Suppl. 3, 33-39
55. Lih-Brody L, Powell SR, Collier KP, et al. (1996) Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41, 2078-2086
56. Barbosa DS, Cecchini R, El Kadri MZ, et al. (2003) Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil v-3 fatty acids. Nutrition 19, 837-842
57. Forrest CM, Gould SR, Darlington LG, et al. (2003) Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol 527, 395-400
58. Kruidenier L, Kuiper I, Lamers CB, et al. (2003) Intestinal oxidative damage in inflammatory bowel disease: Semiquantification, localization, and association with mucosal antioxidants. J Pathol 201, 28-36
59. Xavier RJ & Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434
60. Gecse K, Roka R, Sera T, et al. (2012) Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis. Digestion 85, 40-46
61. Kiesslich R, Duckworth CA, Moussata D, et al. (2012) Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61, 1146-1153
62. Gersemann M, Wehkamp J & Stange EF (2012) Innate immune dysfunction in inflammatory bowel disease. J Intern Med 271, 421-428
63. McGuckin MA, Eri R, Simms LA, et al. (2009) Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 15, 100-113
64. Atreya I, Atreya R & Neurath MF (2008) NF-kappaB in inflammatory bowel disease. J Intern Med 263, 591-596
65. Lennard-Jones JE, Longmore AJ, Newell AC, et al. (1960) An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. Gut 1, 217-222
66. Carter MJ, Lobo AJ & Travis SPL (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53, V1-V16
67. Gionchetti P, Rizzello F, Lammers KM, et al. (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12, 3306-3313
68. Dignass A, Lindsay JO, Sturm A, et al. (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management. J Crohns Colitis 6, 991-1030
69. Manz M, Vavricka SR, Wanner R, et al. (2012) Therapy of steroid-resistant inflammatory bowel disease. Digestion 86, Suppl. 1, 11-15
70. Gonzalez R, Ballester I, Lopez-Posadas R, et al. (2011) Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr 51, 331-362
71. Irving GR, Karmokar A, Berry DP, et al. (2011) Curcumin: The potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol 25, 519-534
72. Neuman MG & Nanau RM (2012) Inflammatory bowel disease: Role of diet, microbiota, life style. Transl Res 160, 29-44
73. Tighe MP, Cummings JR & Afzal NA (2011) Nutrition and inflammatory bowel disease: Primary or adjuvant therapy. Curr Opin Clin Nutr Metab Care 14, 491-496
74. Vernia P, Annese V, Bresci G, et al. (2003) Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: Results of a multicentre trial. Eur J Clin Invest 33, 244-248
75. Rodriguez-Cabezas ME, Galvez J, Lorente MD, et al. (2002) Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr 132, 3263-3271
76. Vieira EL, Leonel AJ, Sad AP, et al. (2012) Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 23, 430-436
77. Nishimura T, Andoh A, Hashimoto T, et al. (2010) Cellobiose prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis. J Clin Biochem Nutr 46, 105-110
78. Koleva PT, Valcheva RS, Sun X, et al. (2012) Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats. Br J Nutr 108, 1633-1643
79. Rodriguez-Cabezas ME, Camuesco D, Arribas B, et al. (2010) The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in rats. Clin Nutr 29, 832-839
80. Moreau NM, Martin LJ, Toquet CS, et al. (2003) Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in Dextran sulfate sodium-induced experimental colitis. Br J Nutr 90, 75-85
81. Andujar I, Recio MC, Giner RM, et al. (2011) Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells. J Agric Food Chem 59, 6474-6483
82. Larrosa M, Gonzalez-Sarrias A, Yanez-Gascon MJ, et al. (2010) Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem 21, 717-725
83. Baliga MS, Joseph N, Venkataranganna MV, et al. (2012) Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: Preclinical and clinical observations. Food Funct 3, 1109-1117
84. Beninger CW & Hosfield GL (1999) Flavonoid composition of three genotypes of dry bean (Phaseolus vulgaris) differing in seed coat color. J Am Soc Hortic Sci 124, 514-518
85. Espinosa-Alonso LG, Lygin A, Widholm JM, et al. (2006) Polyphenols in wild and weedy Mexican common beans (Phaseolus vulgaris L.). J Agric Food Chem 54, 4436-4444
86. Ranilla LG, Genovese MI & Lajolo FM (2007) Polyphenols and antioxidant capacity of seed coat and cotyledon from Brazilian and Peruvian bean cultivars (Phaseolus vulgaris L.). J Agric Food Chem 55, 90-98
87. Masoodi I, Tijjani BM, Wani H, et al. (2011) Biomarkers in the management of ulcerative colitis: A brief review. Ger Med Sci 9, Doc03
88. Charpentier C, Marion-Letellier R, Savoye G, et al. (2012) Magnetic resonance colonography in rats with TNBSinduced colitis: A feasibility and validation study. Inflamm Bowel Dis 18, 1940-1949
89. Sugawara T & Miyazawa T (2001) Beneficial effect of dietary wheat glycolipids on cecum short-chain fatty acid and secondary bile acid profiles in mice. J Nutr Sci Vitaminol (Tokyo) 47, 299-305
90. Sutivisedsak N, Cheng HN, Willett JL, et al. (2010) Microwave-Assisted extraction of phenolics from bean (Phaseolus vulgaris L.). Food Res Int 43, 516-519
91. Espiacute;n JC, González-Barrio R, Cerdá B, et al. (2007) Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J Agric Food Chem 55, 10476-10485
92. Li H, Deng Z, Liu R, et al. (2011) Characterization of phytochemicals and antioxidant activities of a purple tomato (Solanum lycopersicum L.). J Agric Food Chem 59, 11803-11811
93. Zhishen J, Mengcheng T & Jianming W (1999) The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 64, 555-559
94. Campos-Vega R, Garciacute;a-Gasca T, Guevara-Gonzalez R, et al. (2012) Human gut flora-fermented nondigestible fraction from cooked bean (Phaseolus vulgaris L.) modifies protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon cancer cells. J Agric Food Chem 60, 12443-12450
95. Bienvenu JA, Monneret G, Gutowski MC, et al. (1998) Cytokine assays in human sera and tissues. Toxicology 129, 55-61
96. Saemann MD, Bohmig GA, Osterreicher CH, et al. (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: Potent inhibition of IL-12 and up-regulation of IL-10 production. Faseb J 14, 2380-2382
97. Leung CH, Lam W, Ma DL, et al. (2009) Butyrate mediates nucleotide-binding and oligomerisation Domain (NOD) 2-dependent mucosal immune responses against peptidoglycan. Eur J Immunol 39, 3529-3537
98. Blais M, Seidman EG & Asselin C (2007) Dual effect of butyrate on IL-1beta-mediated intestinal epithelial cell inflammatory response. DNA Cell Biol 26, 133-147
99. Romagnani P, Lasagni L, Annunziato F, et al. (2004) CXC chemokines: The regulatory link between inflammation and angiogenesis. Trends Immunol 25, 201-209
100. Topping DL & Clifton PM (2001) Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031-1064
101. Krzystek-Korpacka M, Neubauer K, Berdowska I, et al. (2010) Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: Impact of anemia and treatment. Inflamm Bowel Dis 16, 1467-1475
102. Zhu H & Li YR (2012) Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: Updated experimental and clinical evidence. Exp Biol Med (Maywood) 237, 474-480
103. Rezaie A, Parker RD & Abdollahi M (2007) Oxidative stress and pathogenesis of inflammatory bowel disease: An epiphenomenon or the cause?. Dig Dis Sci 52, 2015-2021
104. Singh UP, Singh NP, Busbee B, et al. (2012) Alternative medicines as emerging therapies for inflammatory bowel diseases. Int Rev Immunol 31, 66-84
105. Oz HS, Chen TS, McClain CJ, et al. (2005) Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem 16, 297-304
106. Millar AD, Rampton DS, Chander CL, et al. (1996) Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39, 407-415
107. Tham DM, Whitin JC & Cohen HJ (2002) Increased expression of extracellular glutathione peroxidase in mice with dextran sodium sulfate-induced experimental colitis. Pediatr Res 51, 641-646
108. Te Velde AA, Pronk I, de Kort F, et al. (2008) Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: An important role for H2O2?. Eur J Gastroenterol Hepatol 20, 555-560
109. Trivedi PP & Jena GB (2012) Dextran sulfate sodiuminduced ulcerative colitis leads to increased hematopoiesis and induces both local as well as systemic genotoxicity in mice. Mutat Res 744, 172-183
110. Kwon KH, Murakami A, Tanaka T, et al. (2005) Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: Attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69, 395-406
111. Camuesco D, Comalada M, Concha A, et al. (2006) Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin Nutr 25, 466-476
112. Villegas I, Alarcon De la Lastra C, Orjales A, et al. (2003) A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. Int Immunopharmacol 3, 1731-1741
113. Melgar S, Karlsson L, Rehnstrom E, et al. (2008) Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol 8, 836-844
114. Islam MS, Murata T, Fujisawa M, et al. (2008) Antiinflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. Br J Pharmacol 154, 812-824
115. Ruiz PA, Braune A, Holzlwimmer G, et al. (2007) Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr 137, 1208-1215
116. Kim H, Kong H, Choi B, et al. (2005) Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res 22, 1499-1509
117. Deguchi Y, Andoh A, Inatomi O, et al. (2007) Curcumin prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis. Dig Dis Sci 52, 2993-2998
118. Akiyama S, Nesumi A, Maeda-Yamamoto M, et al. (2012) Effects of anthocyanin-rich tea 'Sunrouge' on Dextran sodium sulfate-induced colitis in mice. Biofactors 38, 226-233
119. Piberger H, Oehme A, Hofmann C, et al. (2011) Bilberries and their anthocyanins ameliorate experimental colitis. Mol Nutr Food Res 55, 1724-1729
120. Kidd VJ (1998) Proteolytic activities that mediate apoptosis. Annu Rev Physiol 60, 533-573
121. Goretsky T, Dirisina R, Sinh P, et al. (2012) p53 mediates TNF-induced epithelial cell apoptosis in IBD. Am J Pathol 181, 1306-1315
122. Rieder F, Karrasch T, Ben-Horin S, et al. (2012) Results of the 2nd scientific workshop of the ECCO (III): Basic mechanisms of intestinal healing. J Crohns Colitis 6, 373-385
123. Iizuka M & Konno S (2011) Wound healing of intestinal epithelial cells. World J Gastroenterol 17, 2161-2171
124. Ho SB, Dvorak LA, Moor RE, et al. (2006) Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 131, 1501-1517
125. Deshpande SS, Sathe SK & Salunkhe DK (1984) Dry beans of Phaseolus: A review. Part 3. Crit Rev Food Sci Nutr 21, 137-195
126. Kumar S, Verma AK, Das M, et al. (2013) Clinical complications of kidney bean (Phaseolus vulgaris L.) consumption. Nutrition 29, 821-827
127. Zhu Z, Jiang W & Thompson HJ (2012) Edible dry bean consumption (Phaseolus vulgaris L.) modulates cardiovascular risk factors and diet-induced obesity in rats and mice. Br J Nutr 108, Suppl. 1, S66-S73
128. Rondini EA & Bennink MR (2012) Microarray analyses of genes differentially expressed by diet (black beans and soy flour) during azoxymethane-induced colon carcinogenesis in rats. J Nutr Metab 2012, 351796
129. Hughes JS, Ganthavorn C & Wilson-Sanders S (1997) Dry beans inhibit azoxymethane-induced colon carcinogenesis in F344 rats. J Nutr 127, 2328-2333
130. Key FB, McClean D & Mathers JC (1996) Tissue hypertrophy and epithelial proliferation rate in the gut of rats fed on bread and haricot beans (Phaseolus vulgaris). Br J Nutr 76, 273-286
131. Kumar V, Sinha AK, Makkar HP, et al. (2012) Dietary roles of non-starch polysaccharides in human nutrition: A review. Crit Rev Food Sci Nutr 52, 899-935
132. Hou J & Sellin J (2010) Diet, nutrition and inflammatory bowel disease. Therapy 7, 179-189
133. Nanau RM & Neuman MG (2012) Nutritional and probiotic supplementation in colitis models. Dig Dis Sci 57, 2786-2810
134. Abia R, Buchanan CJ, Saura-Calixto F, et al. (1993) Structural changes during the retrogradation of legume starches modify the in vitro fermentation. J Agric Food Chem 41, 1856-1863
135. Jenkins DJ, Kendall CW, Augustin LS, et al. (2012) Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: A randomised controlled trial. Arch Intern Med 172, 1653-1660